↓ Skip to main content

Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, April 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation
Published in
Journal of Experimental & Clinical Cancer Research, April 2012
DOI 10.1186/1756-9966-31-33
Pubmed ID
Authors

Antonello Vidiri, Andrea Pace, Alessandra Fabi, Marta Maschio, Gaetano Marco Latagliata, Vincenzo Anelli, Francesca Piludu, Carmine Maria Carapella, Giuseppe Giovinazzo, Simona Marzi

Abstract

To determine whether early monitoring of the effects of bevacizumab in patients with recurrent high-grade gliomas, by a Perfusion Computed Tomography (PCT), may be a predictor of the response to treatment assessed through conventional MRI follow-up.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 15%
Student > Ph. D. Student 4 12%
Professor > Associate Professor 4 12%
Student > Bachelor 3 9%
Student > Master 3 9%
Other 6 18%
Unknown 8 24%
Readers by discipline Count As %
Medicine and Dentistry 14 42%
Neuroscience 3 9%
Physics and Astronomy 3 9%
Agricultural and Biological Sciences 2 6%
Nursing and Health Professions 1 3%
Other 1 3%
Unknown 9 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2012.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#1,967
of 2,378 outputs
Outputs of similar age
#158,003
of 173,991 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#8
of 12 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,378 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,991 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.